<h3 class="title">Diabetes Screening and Diagnosis</h3>

<table class="table">
  <thead>
    <tr>
      <th><strong>Criteria for Diabetes Diagnosis: 4 options</strong></th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>
        <strong>FPG &#8805;126 mg/dL (7.0 mmol/L)*</strong>
        <br />Fasting is defined as no caloric intake for &#8805;8 hours
      </td>
    </tr>
    <tr>
      <td>
        <strong>2-hr PG &#8805;200 mg/dL (11.1 mmol/L) during OGTT (75-g)*</strong>
        <br />Using a glucose load containing the equivalent of 75g anhydrous glucose dissolved in water
      </td>
    </tr>
    <tr>
      <td>
        <strong>A1C &#8805;6.5% (48 mmol/mol)*</strong>
        <br />
        <em>Performed in a lab using NGSP-certified method and standardized to DCCT assay</em>
      </td>
    </tr>
    <tr>
      <td>
        <strong>Random PG &#8805;200 mg/dL (11.1 mmol/L)</strong>
        <br />In individuals with symptoms of hyperglycemia or hyperglycemic crisis
      </td>
    </tr>
    <tr>
      <td>
        <ul style="list-style-type: disc; margin-left: 10px;">
          <li>No clear clinical diagnosis? Immediately repeat the same test using a new blood sample.</li>
          <li>Same test with same or similar results? Diagnosis confirmed.</li>
          <li>Different tests above diagnostic threshold? Diagnosis confirmed.</li>
          <li>Discordant results from two separate tests? Repeat the test with a result above diagnostic cut-point.</li>
        </ul>&nbsp;
      </td>
    </tr>
    <tr>
      <td>
        *In absence of unequivocal hyperglycemia, result to be confirmed by repeat testing
      </td>
    </tr>
  </tbody>
</table>

<table class="table">
  <thead>
    <tr>
      <th><strong>Testing for Type 2 Diabetes and Prediabetes in Asymptomatic Adults</strong></th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>
        <p>Type 2 diabetes screening should be performed in adults of any age who are overweight or obese, and who have one or more diabetes risk factor (
          <em>See Diabetes Risk Factors</em>)
        </p>
        <ul style="list-style-type: disc; margin-left: 10px;">
          <li>Testing should begin at age 45 </li>
          <li>If test is normal? Repeat it at least every 3 years </li>
        </ul>
      </td>
    </tr>
    <tr>
      <td>
        <p>Screening for prediabetes can be done using A1C, FPG, or 2-hr PG after 75-g OGTT criteria </p>
        <ul style="list-style-type: disc; margin-left: 10px;">
          <li>CVD risk factors should be identified and treated </li>
          <li>Testing may be considered in children and adolescents who are overweight or obese and have two or more risk factors for diabetes (
            <em>See Diabetes Risk Factors</em>)
          </li>
        </ul>
      </td>
    </tr>
  </tbody>
</table>

<table class="table">
  <thead>
    <tr>
      <th colspan="3">
        <strong>Categories of Increased Risk for Diabetes (Prediabetes)</strong>
      </th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>
        <strong>FPG</strong>
      </td>
      <td>
        <strong>2-hr PG</strong>
      </td>
      <td>
        <strong>A1C</strong>
      </td>
    </tr>
    <tr>
      <td>
        100-125 mg/dL
        <br />(5.6-6.9 mmol/L)
        <br />
        <em>Impaired fasting glucose (IFG) </em>
      </td>
      <td>
        140-199 mg/dL
        <br />(7.8-11.0 mmol/L)
        <br />
        <em>Impaired glucose tolerance (IGT)</em>
      </td>
      <td>
        5.7-6.4%
        <br />(39-46 mmol/mol)
      </td>
    </tr>
    <tr>
      <td colspan="3">
        For all tests, risk is continuous, extending below lower limit of range
        <br />and becoming disproportionately greater at higher ends of range
      </td>
    </tr>
  </tbody>
</table>

<table class="table">
  <thead>
    <tr>
      <td colspan="2">
        <strong>Type 2 Diabetes Risk Factors</strong>
      </td>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>
        <ul style="list-style-type: disc; margin-left: 10px;">
          <li>Physical inactivity</li>
        </ul>
      </td>
      <td>
        <ul style="list-style-type: disc; margin-left: 10px;">
          <li>First-degree relative with diabetes*</li>
        </ul>
      </td>
    </tr>
    <tr>
      <td>
        <ul style="list-style-type: disc; margin-left: 10px;">
          <li>High-risk race or ethnicity</li>
        </ul>
      </td>
      <td>
        <ul style="list-style-type: disc; margin-left: 10px;">
          <li>Women who delivered a baby weighing &gt;9 lb or who have previously been diagnosed with GDM</li>
        </ul>
      </td>
    </tr>
    <tr>
      <td>
        <ul style="list-style-type: disc; margin-left: 10px;">
          <li>HDL-C &lt;35 mg/dL and/or TG &gt;250 mg/dL</li>
        </ul>
      </td>
      <td>
        <ul style="list-style-type: disc; margin-left: 10px;">
          <li>A1C &#8805;5.7%, IGT, or IFG</li>
        </ul>
      </td>
    </tr>
    <tr>
      <td>
        <ul style="list-style-type: disc; margin-left: 10px;">
          <li>Hypertension (&#8805;140/90 or on treatment)</li>
        </ul>
      </td>
      <td>
        <ul style="list-style-type: disc; margin-left: 10px;">
          <li>History of cardiovascular disease</li>
        </ul>
      </td>
    </tr>
    <tr>
      <td colspan="2">
        <ul style="list-style-type: disc; margin-left: 10px;">
          <li>Conditions associated with insulin resistance
            <sup>†</sup>
          </li>
        </ul>
      </td>
    </tr>
    <tr>
      <td colspan="2">
        *African-American, Latino, Native American, Asian American, Pacific Islander
        <br />
        <sup>†</sup>Severe obesity, acanthosis nigricans, polycystic ovarian syndrome
      </td>
    </tr>
  </tbody>
</table>

<table class="table">
  <thead>
    <tr>
      <th>
        <strong>Screening Children for Type 2 Diabetes and Prediabetes</strong>
      </th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>
        Consider screening for type 2 diabetes and prediabetes for all children who are overweight* and have two or more of the following risk factors:
        <ul>
          <li>Family history of type 2 diabetes in a first- or second-degree relative</li>
          <li>Native American, African American, Latino, Asian American, or Pacific Islander descent</li>
          <li>Signs of insulin resistance or conditions associated with insulin resistance
            <sup>†</sup>
          </li>
          <li>Maternal history of diabetes or GDM during the child’s gestation</li>
        </ul>
      </td>
    </tr>
    <tr>
      <td>Test every 3 years using A1C beginning at age 10 or onset of puberty</td>
    </tr>
    <tr>
      <td>*BMI &gt;85th percentile for age and sex, weight for height &gt;85th percentile, or weight &gt;120% ideal weight
        <br />
        <sup>†</sup>Acanthosis nigricans, hypertension, dyslipidemia, polycystic ovarian syndrome, or small-for-gestational-age birth weight
        <br />Children defined as age &lt;18 years
      </td>
    </tr>
  </tbody>
</table>
<table class="table">
  <thead>
    <tr>
      <th colspan="2">
        <strong>Screening for Gestational Diabetes (GDM)</strong>
      </th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Pregnant women with risk factors</td>
      <td>Test for undiagnosed type 2 at first prenatal visit using standard diagnostic criteria</td>
    </tr>
    <tr>
      <td>Pregnant women without known prior diabetes</td>
      <td>Test for GDM at 24-28 weeks</td>
    </tr>
    <tr>
      <td>Women with GDM</td>
      <td>Screen for persistent diabetes 6-12 wks postpartum using OGTT and standard diagnostic criteria</td>
    </tr>
    <tr>
      <td>Women with a history of GDM</td>
      <td>Lifelong screening for diabetes or prediabetes every &#8805;3 yrs</td>
    </tr>
    <tr>
      <td>Women with a history of GDM and prediabetes</td>
      <td>Lifestyle interventions or metformin for diabetes prevention</td>
    </tr>
    <tr>
      <td colspan="2">
        <ul>
          <li>Women with diabetes in the first trimester have type 2 diabetes</li>
          <li>GDM is diagnosed in the second or third trimester and not clearly associated with type 1 or type 2 diabetes</li>
        </ul>
      </td>
    </tr>
    <tr>
      <td colspan="2">
        Screening is recommended at 24-48 weeks in women
        <br />who were not previously diagnosed with overt diabetes
      </td>
    </tr>
    <tr>
      <td>
        <strong>One-step diagnosis strategy</strong>
      </td>
      <td>
        <strong>Two-step diagnosis strategy</strong>
      </td>
    </tr>
    <tr>
      <td>
        <ul>
          <li>Perform 75-g OGTT with plasma glucose measurement</li>
          <li>Test in the morning after the patient has fasted for &#8805;8 hours</li>
          <li>Repeat test at 1 and 2 hours after initial measurement</li>
        </ul>
      </td>
      <td>
        Step 1:
        <ul>
          <li>Perform a 50-g nonfasting GLT with plasma measurement at 1 hour</li>
          <li>If PG measured 1 hour after the load is &#8805;140 mg/dL (7.8 mmol/L), proceed to 100-g OGTT</li>
        </ul>
      </td>
    </tr>
    <tr>
      <td>
        Diagnosis is confirmed when PG levels meet or exceed:
        <ul>
          <li>Fasting 92 mg/dL (5.1 mmol/L)</li>
          <li>1 hr: 180 mg/dL (10.0 mmol/L)</li>
          <li>2 hr: 153 mg/dL (8.5 mmol/L)</li>
        </ul>
      </td>
      <td>
        Step 2:
        <ul>
          <li>Perform 100-g OGTT while patient is fasting</li>
        </ul>
        Diagnosis is confirmed when two or more PG levels meet or exceed:
        <ul>
          <li>Fasting: 95 mg/dL or 105 mg/dL (5.3/5.8)</li>
          <li>1 hr: 180 mg/dL or 190 mg/dL (10.0/10.6)</li>
          <li>2 hr: 155 mg/dL or 165 mg/dL (8.6/9.2)</li>
          <li>3 hr: 140 mg/dL or 145 mg/dL (7.8/8.0)</li>
        </ul>
      </td>
    </tr>
  </tbody>
</table>

<table class="table">
  <thead>
    <tr>
      <th>
        <strong>Screening for Type 1 Diabetes</strong>
      </th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>There are two manifestations of type 1 diabetes:
        <ul>
          <li>Immune-mediated diabetes, previously called “insulin-dependent diabetes” or “juvenile-onset diabetes”, is due to cellular-mediated autoimmune destruction of beta-cells</li>
          <li>Idiopathic type 1 diabetes largely has no known cause with no evidence of beta-cell autoimmunity</li>
        </ul>
      </td>
    </tr>
    <tr>
      <td>Blood glucose is preferred over A1C to diagnose acute onset of type 1 diabetes with symptoms of hyperglycemia</td>
    </tr>
    <tr>
      <td>Inform relatives of individuals with type 1 diabetes of the opportunity to be tested
        <ul>
          <li>Testing should occur only in the setting of a clinical research study</li>
        </ul>
      </td>
    </tr>
  </tbody>
</table>

<p>
  Cited from: <a target="_blank" href="http://www.ndei.org/ADA-2013-Guidelines-Criteria-Diabetes-Diagnosis.aspx.html">American Diabetes Association (ADA) 2016 Guidelines</a>
</p>
